Testing for inherited genetic mutations predisposing to cancer development. Identifies high-risk individuals for enhanced surveillance and preventive strategies.
Manufactured by
Guangdong Guangzhou, China
Burning Rock Dx (NASDAQ: BNR) is a global precision oncology leader specializing in NGS-based diagnostics for both tissue and liquid biopsy. With internationally accredited labs (CLIA, CAP, ISO15189, ISO13485) and deep NGS expertise, the company offers a broad portfolio of in-house assays and integrated solutions across the oncology development cycle. Burning Rock supports pharmaceutical development and decentralized clinical implementation, partnering with biopharma and clinical labs to advance trials, biomarker research, and real-world diagnostics. Key milestones include two NMPA-approved IVD kits, four CE-marked assays, and Breakthrough Device Designations from both the FDA and NMPA for its multi-cancer early detection test. Burning Rock is committed to transforming cancer care through innovative, science-driven solutions. In addition to the CLIA / CAP laboratory in the United States, we have a CLIA / CAP / ISO 15189 / ISO13485 lab in Guangzhou, China, which also obtained the technical certification of “High-throughput sequencing laboratory” issued by the Guangdong Center for Clinical Laboratory. We have passed over 200 inter-laboratory quality evaluations organized by NCCL, PQCC, EMQN, CAP, and other authoritative organizations.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
HAGMED Sp. z o.o. Sp. k.
Poland · 1 relevant product
Trivitron Healthcare Private Limited
India · 1 relevant product
Origin Biotechnology Co., Ltd.
Taiwan · 6 relevant products
Axbio (shenzhen) Co.,LTD
China · 2 relevant products
Daan Gene Co., Ltd.
China · 2 relevant products
Acon Biotech (Hangzhou) Co., Ltd.
China · 3 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 6 relevant products
Biomerica, Inc.
United States · 2 relevant products
ACON Laboratories, Inc.
United States · 1 relevant product
48 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 99 closest product alternatives
HAGMED Sp. z o.o. Sp. k. · Poland
Collection kits designed for genetic screening to identify predisposition to hereditary diseases. These kits enable early detection of genetic risk factors in family populations.
Trivitron Healthcare Private Limited · India
Specialized screening tests for hereditary and genetic disorders in newborns and populations, utilizing advanced biochemical and molecular techniques for early disease detection.
Origin Biotechnology Co., Ltd. · Taiwan
A molecular medicine-based screening test for prenatal diagnosis and prevention of genetic abnormalities. The test provides rapid results to support clinical decision-making in maternal-fetal medicine.
Axbio (shenzhen) Co.,LTD · China
Diagnostic test kit for identification of genetic mutations and inherited disorders through nucleic acid sequencing. Supports clinical genetic testing and carrier screening applications.
Daan Gene Co., Ltd. · China
PCR-based screening kit for hereditary genetic disease detection. Identifies genetic mutations associated with inherited conditions in patient samples.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for prenatal screening and fetal abnormality detection. Assesses risk for genetic and chromosomal disorders.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cancer screening and early detection. Part of the comprehensive oncology testing portfolio covering multiple cancer types.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based molecular diagnostic test designed for early detection and risk assessment across multiple cancer types. The test utilizes proprietary methylation technology to identify cancer signals in biological samples.
Daan Gene Co., Ltd. · China
Comprehensive PCR-based screening panel for multiple genetic diseases. Allows simultaneous detection of multiple genetic markers in single analysis.
Biomerica, Inc. · United States
An advanced diagnostic test for prostate cancer screening. Designed as an at-home screening product targeting high-prevalence cancer detection.
ACON Laboratories, Inc. · United States
Qualitative screening immunoassay for the detection of cancer markers. Designed for reliable and accessible cancer risk assessment in point-of-care settings.
Origin Biotechnology Co., Ltd. · Taiwan
A diagnostic service for prenatal screening and diagnosis, focusing on molecular detection techniques for maternal and fetal health assessment.
87 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products